Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy

Simple item page
dc.contributor.authorBerenguer, Juan
dc.contributor.authorGonzález, Juan
dc.contributor.authorPulido Ortega, Federico
dc.contributor.authorPadilla, Belén
dc.contributor.authorCasado, José Luis
dc.contributor.authorRubio García, Rafael
dc.contributor.authorArribas, José Ramón
dc.date.accessioned2024-07-31T12:14:53Z
dc.date.available2024-07-31T12:14:53Z
dc.date.issued2002-02-01
dc.description.abstractWe performed a prospective study of discontinuation of secondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and quiescent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with persistent response to HAART, findings that support the discontinuation of secondary prophylaxis against CMV retinitis in such patients.
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.citationBerenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR; Madrid Group for the Study of Discontinuation of Secondary Prophylaxis in Patients with CMV Retinitis. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clin Infect Dis. 2002 Feb 1;34(3):394-7
dc.identifier.doi10.1086/338401
dc.identifier.essn1537-6591
dc.identifier.issn1058-4838
dc.identifier.officialurlhttps://doi.org/10.1086/338401
dc.identifier.relatedurlhttps://academic.oup.com/cid/article/34/3/394/390106
dc.identifier.urihttps://hdl.handle.net/20.500.14352/107324
dc.issue.number3
dc.journal.titleClinical Infectious Diseases
dc.language.isoeng
dc.page.final397
dc.page.initial394
dc.publisherOxford University Press
dc.rights.accessRightsrestricted access
dc.subject.cdu616.98VIH
dc.subject.keywordCMV retinitis
dc.subject.keywordSecondary Prophylaxis
dc.subject.keywordHIV
dc.subject.keywordAIDS
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco24 Ciencias de la Vida
dc.titleDiscontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number34
dspace.entity.typePublication
relation.isAuthorOfPublicationff09a346-4600-4af0-bd7c-33d06d5dca87
relation.isAuthorOfPublication4921ba5d-98d9-4deb-86fa-a2f419fb69fe
relation.isAuthorOfPublication.latestForDiscovery4921ba5d-98d9-4deb-86fa-a2f419fb69fe

Download

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2002. Clin Infect Dis. CMV- Berenguer.pdf
Size:
86.69 KB
Format:
Adobe Portable Document Format
Download

Collections

Artículos